Recently, using an HK2 conditional knockout mouse, a group showed that HK2 is required for tumor initiation and maintenance in mouse models of KRas-driven lung cancer [43], lending further evidence that HK2 is a key metabolic driver in cancer, and an attractive target in cancer biology. Here, HK2 is linked to lung cancer.